Startup Genzada to build new HQ, renovate manufacturing facility in Kansas

Startup drugmaker Genzada Pharmaceuticals said it will build new headquarters in Sterling, KS, and renovate an existing building to house a “small-scale” manufacturing facility and R&D facility.

The company said it expects to create as many as 25 to 30 new jobs in the south-central Kansas town. The expansion for the headquarters is expected to be 10,000-square feet and be completed sometime next year, KWCH12 reported.

"The new space will allow us to continue to expand on achieving our mission, which is to eliminate diseases that induce human suffering,” Jason West, Genzada’s EVP, told the television station.


Survey: The Critical Role of Innovation in Launching Successful OTC Products

This research aims to understand the importance of product innovation and dose forms in driving new product design and development, consumer engagement and purchase interest for Over-the-Counter medicines. The first 50 qualified respondents will receive a $5 Amazon gift card. Take the survey now.

The company plans to seek FDA approval next year for human testing of various pharmaceutical products for rare and hard-to-treat cancers and other medical conditions.

Genzada has conducted studies with a combination of three chemical compounds, including a pair from plant-based material, West said.

-here’s the KWCH12 story

Suggested Articles

Pfizer is ponying up $500 million on top of $100 million already committed to a gene therapy manufacturing facility in North Carolina.

Hikma says it has picked up some pipeline products and nasal and sublingual spray equipment from Insys Therapeutics' bankruptcy.

WuXi Biologics expects to have a plant in Europe complete in 2021 as a capacity race plays out among Asia’s rapidly growing biologics CDMOs.